InvestorsHub Logo
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: None

Tuesday, 08/04/2020 2:51:24 PM

Tuesday, August 04, 2020 2:51:24 PM

Post# of 42856
Fauci picked HGEN Lenzilumab over the Regeneron antibody mixture, Over Convalescent Plasma, over anti CCR5 CYDY Leronilumab, and over all other GMCSF agents from GSK, Kiniska, Izana, and Roivant- to partner with barely significant GILD Remdesivir. I suppose the NIAID Director feels the paring is most likely to be synergistic.